Alembic Pharmaceuticals Limited (NSE:APLLTD)
India · Delayed Price · Currency is INR 735.00
-2.20 (-0.30%)
Jun 11, 2026, 9:35 AM IST
Alembic Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Alembic Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of ₹907.20. The average 1-year stock price forecast is 23.43% higher than the current stock price, while the lowest is ₹715.00 (-2.72%) and the highest is ₹1,132 (+54.01%).
Price Target: ₹907.20 (+23.43%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Alembic Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 4 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 4 | 4 | 4 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 12 | 12 | 12 | 11 | 11 | 10 |
Financial Forecast
Revenue This Year
81.92B
from 73.45B
Increased by 11.53%
Revenue Next Year
90.42B
from 81.92B
Increased by 10.38%
EPS This Year
37.72
from 37.62
Increased by 0.25%
EPS Next Year
48.50
from 37.72
Increased by 28.58%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 82.8B | ||
| Avg | 81.9B | ||
| Low | 81.1B |
Revenue Growth
| Revenue Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 12.7% | ||
| Avg | 11.5% | ||
| Low | 10.4% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | - | ||
| Avg | 37.72 | ||
| Low | - |
EPS Growth
| EPS Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | - | ||
| Avg | 0.3% | ||
| Low | - |